Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 13
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Bernstein, Lori J. Catton, Pamela A. and Tannock, Ian F. 2014. Intra-individual Variability in Women with Breast Cancer. Journal of the International Neuropsychological Society, Vol. 20, Issue. 04, p. 380.

    Zipursky, Amy R. Gogolishvili, David Rueda, Sergio Brunetta, Jason Carvalhal, Adriana McCombe, Jennifer A. Gill, M. John Rachlis, Anita Rosenes, Ron Arbess, Gordon Marcotte, Thomas and Rourke, Sean B. 2013. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS. AIDS, Vol. 27, Issue. 15, p. 2385.

    Argyriou, Andreas A. Assimakopoulos, Konstantinos Iconomou, Gregoris Giannakopoulou, Fotini and Kalofonos, Haralabos P. 2011. Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real. Journal of Pain and Symptom Management, Vol. 41, Issue. 1, p. 126.

    Tussey, Chriscelyn M. Broshek, Donna K. and Marcopulos, Bernice A. 2010. Handbook of Assessment in Clinical Gerontology.

    Mar Fan, H.G. Park, A. Xu, W. Yi, Q-L. Braganza, S. Chang, J. Couture, F. and Tannock, I.F. 2009. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psycho-Oncology, Vol. 18, Issue. 2, p. 156.

    Marín, Álvaro Pinto Sánchez, Andrés Redondo Arranz, Enrique Espinosa Auñón, Pilar Zamora and Barón, Manuel González 2009. Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment. Southern Medical Journal, Vol. 102, Issue. 9, p. 929.

    Ouimet, L. A. Stewart, A. Collins, B. Schindler, D. and Bielajew, C. 2009. Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology, Vol. 31, Issue. 1, p. 73.

    Mar Fan, Helen G. Clemons, Mark Xu, Wei Chemerynsky, Irene Breunis, Henriette Braganza, Sharon and Tannock, Ian F. 2008. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Supportive Care in Cancer, Vol. 16, Issue. 6, p. 577.

    Bottiggi, Kara Anne Chang, Jason J. Schmitt, Frederick A. Avison, Malcolm J. Mootoor, Yunanan Nath, Avindra and Berger, Joseph R. 2007. The HIV Dementia Scale: Predictive power in mild dementia and HAART. Journal of the Neurological Sciences, Vol. 260, Issue. 1-2, p. 11.

    Downie, Fiona P. Mar Fan, Helen G. Houédé-Tchen, Nadine Yi, QiLong and Tannock, Ian F. 2006. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho-Oncology, Vol. 15, Issue. 10, p. 921.

    Hensley, Martee L. Correa, Denise D. Thaler, Howard Wilton, Andrew Venkatraman, Ennapadam Sabbatini, Paul Chi, Dennis S. Dupont, Jakob Spriggs, David and Aghajanian, Carol 2006. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology, Vol. 102, Issue. 2, p. 270.

    Joly, F. Alibhai, S.M.H. Galica, J. Park, A. Yi, Q.-L. Wagner, L. and Tannock, I.F. 2006. Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer. The Journal of Urology, Vol. 176, Issue. 6, p. 2443.

    Vardy, Janette Wong, Karen Yi, Qi-long Park, Alison Maruff, Paul Wagner, Lynne and Tannock, Ian F. 2006. Assessing cognitive function in cancer patients. Supportive Care in Cancer, Vol. 14, Issue. 11, p. 1111.


The High Sensitivity Cognitive Screen

  • Barry S. Fogel (a1)
  • DOI:
  • Published online: 01 December 1991

Ceiling effects limit the utility of many established brief cognitive screening tests for detecting and measuring mild delirious states and prodromal disorders. The High Sensitivity Cognitive Screen (HSCS) (Faust & Fogel, 1989), a bedside test taking approximately 25 minutes to administer, may overcome this limitation. The test consists of a selection of moderately difficult items testing six major domains of neuropsychological performance: memory, language, attention/concentration, visual/motor, spatial, and self-regulation and planning. Reliability is adequate, and two separate concurrent validity studies show accuracy rates of 93% and 87% in classifying the overall result of comprehensive neuropsychological testing. HSCS performance is highly correlated with EEG results in medical psychiatric inpatients, and with functional status in HIV-infected community-dwelling subjects. The brevity and convenience of the HSCS and related instruments make them particularly useful in studies of elderly and chronically ill subjects.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *